EVOLENT HEALTH INC CLASS A (EVH)
Health Care · Health care services / population health management · NYSE
Evolent Health manages complex specialty care, such as oncology and cardiology, using clinical technology and provider networks to help health plans lower costs and improve health outcomes.
What EVOLENT HEALTH INC CLASS A does
Evolent Health provides specialty care management services, primarily focused on oncology, cardiology, and musculoskeletal conditions, to help health plans and risk-bearing entities manage complex patient needs. The company utilizes clinical pathways, provider network management, and proprietary technology to reduce healthcare costs and improve clinical outcomes for patients. Its solutions integrate analytics, pharmacy management, and physician engagement to facilitate evidence-based care delivery.
Recent developments
Evolent announced an upcoming Oncology Performance Suite partnership with an existing client expected to generate approximately $300 million in annualized revenue upon its December 2026 launch. For 2027, the company forecasts revenue growth exceeding 25% compared to 2026 and expects an Adjusted EBITDA midpoint at or above $150 million. Management is focused on improved performance suite margins, expense reduction, and potential debt reduction initiatives to enhance financial flexibility.
From EVOLENT HEALTH INC CLASS A's filing of 2026-08-06.
Themes: value-based care, specialty care management, healthcare analytics, clinical decision support, oncology care management, cardiology care management, AI-led healthcare operations
Fundamentals
- Price$3.96 as of 2026-10-08 close
- Market cap$448M as of 2026-08-01 (share count; price 2026-10-08)
- 1-year return-50.8% 2025-10-08 close $8.05 → 2026-10-08 close $3.96
- P/En/a negative earnings
- Net margin-28.5% FY2025, SEC XBRL
- ROE-128.7% FY2025, SEC XBRL
- Debt / equity2.52 as of 2026-09-03
- Revenue growth (YoY)-4.5% as of 2026-09-03
- Revenue CAGR (3y)+11.5% SEC XBRL
- Beta0.71 as of 2026-09-03
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How EVH compares in its sector
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- return on equitybottom 25% 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How EVOLENT HEALTH INC CLASS A looks technically
EVOLENT HEALTH INC CLASS A (EVH) is trading 3.6% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 64 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 27, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 3 trading days ago (its momentum flipped positive). It made a new 20-day low about 6 trading days ago. It is 53.2% below its highest point of the past year.
Trend
9
| Distance from the 200-day | it is trading 3.6% above its 200-day average, the long-term trend line — a longer-term uptrend | +3.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $4.00 | $4.00 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $3.82 | $3.82 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 43 calendar days ago — the swings before that are what the structure reading is measured on | 43 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 5.03. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 64 trading days ago — a "golden cross", a bullish long-term signal | 64 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 3.6% above | +3.6% |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 27, with buyers in control | 27.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30) | 52.8 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($3.32 to $4.17) — its "stochastic" reading is 75 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 74.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 3 trading days ago (its momentum flipped positive) | 3 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $8.46 | $8.46 |
|---|---|---|
| From the 52-week high | it is 53.2% below its 52-week high (its highest price of the past year) | -53.2% |
| Above the 52-week low | it is 89.0% above its 52-week low (its lowest price of the past year) | +89.0% |
| Below the 52-week high | it is 53.2% below its highest point of the past year | 53.2% |
| Since a 20-day breakout | it made a new 20-day low about 6 trading days ago | 6 sessions |
| Since a 55-day breakout | it made a new 55-day low about 46 trading days ago | 46 sessions |
| All-time high | its highest closing price on record is $39.78 (set on 2022-09-15) | $39.78 |
| Given back of the 52-week move | over the past year its closes ranged ($2.17 to $8.25), and it has recovered roughly a quarter of its fall from last year’s high — 29% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $5.93 to $6.12. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 29.4% |
| From the all-time high | it is 90.0% below its all-time high | -90.0% |
| Nearest price level | it is trading 7.1% above a support level at $3.68 — a price it turned at three times since 2026-03-04, most recently on 2026-05-27. Since 2024-10-08 it has 1 such level below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -7.1% |
| All-time low | its lowest closing price on record is $2.10 (set on 2026-04-02) | $2.10 |
| Above the all-time low | it is 89.0% above its all-time low | +89.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 85% of it) | 15th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2428 between its high and its low — about 6.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2428 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $3.28 and $4.16 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $3.28 – $3.72 – $4.16 |
| Typical daily range (% of price) | its price moves about 6.1% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.1% |
| Stretch from the 200-day average | it is trading 0.6 daily ranges above its 200-day average price (3.6% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.6 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.24× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bearish engulfing | 7 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 7 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-08 1.0% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -1.0% |
|---|---|---|
| Open gap | it gapped 32.5% above the previous close 44 sessions ago and has not traded back through the level it left behind at 3.08 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +32.5% |
| Gap filled | a 2.5% gap up opened on 2026-09-16 has been "filled" 16 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 16 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 7.2 percentage points (the stock lost 6.2% while the market gained 1.0%) | -7.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 33.1 percentage points (the stock lost 29.3% while the market gained 3.8%) | -33.1% |
| vs market, 6 months | over the past 6 months this stock beat the market by 54.0 percentage points (the stock gained 71.4% while the market gained 17.5%) | +54.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 65.8 percentage points (the stock lost 50.8% while the market gained 15.0%) | -65.8% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, a strong uptrend, with buyers in control, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 8.0% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 7.5% of the share price. | -8.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $3.74 — a volume-weighted average of daily closes over 191 sessions, not a true tick-by-tick VWAP. | +5.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% below the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is under water. That average is $4.09 — a volume-weighted average of daily closes over 45 sessions, not a true tick-by-tick VWAP. | -3.1% |
Price levels it has turned at before
EVH last closed at $3.96 on 2026-10-08. Since 2024-10-08 it has turned at 1 price below its last close and 9 above; the nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $3.68 | Support | 7.1% below the last close | turned there three times · 2026-03-04 to 2026-05-27 |
| $4.26 | Resistance | 7.7% above the last close | turned there four times · 2025-12-15 to 2026-06-22 |
| $4.54 | Resistance | 14.7% above the last close | turned there twice · 2025-11-24 to 2026-05-07 |
| $8.31 | Resistance | 109.8% above the last close | turned there five times · 2025-03-05 to 2025-10-22 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $5.03.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $5.03.
This reading has stood for 24 trading days, since 2026-09-04.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · in a strong, established uptrend (ADX) · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.71 mean, 1=Strong Buy…5=Strong Sell) — 12 analysts
- Mean price target$5.75 range $3.00 – $8.00; median $6.00
Analyst estimates, as of 2026-10-08. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for EVH
- Consensus EPS estimate$0.06 next reporting period, as of 2026-10-08
- Estimate change, 30 days-$0.00005 from $0.06005, on 2026-09-03, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on a limited number of large health plan customers and risk of membership attrition.","Regulatory and operational risks associated with managing specialty care under performance-based contracts.","Significant historical net losses and the need to manage capital structure and liquidity."]
What changed in the latest 10-Q
AI-assisted comparison of EVH's 10-Q filed 2026-08-06 against the prior one filed 2026-05-07.
Risk Factors
- Added:
- In the filing dated 2026-08-06, Item 5 includes disclosure that Seth Blackley, CEO and Board member, adopted a Rule 10b5-1 trading plan on May 22, 2026, with the first possible trade date of December 15, 2026, end date of February 1, 2027, and aggregate amount of 298,129 shares.
- In the filing dated 2026-08-06, Item 5 includes disclosure that Daniel McCarthy, President, adopted a Rule 10b5-1 trading plan on May 22, 2026, with the first possible trade date of August 21, 2026, end date of February 19, 2027, and aggregate amount of 201,320 shares.
- Removed:
- The filing dated 2026-05-07 includes a description of Retention Award Agreements approved on May 5, 2026 for Messrs. Blackley, McCarthy and Weinberg, with aggregate amounts of $880,000, $660,000 and $350,000 respectively, payable in two installments of 50% on December 31, 2026 and July 1, 2027; this description is not present in the filing dated 2026-08-06.
- Reworded:
- The quarter-end date referenced in the risk factor statement changed from 'quarter ended March 31, 2026' in the filing dated 2026-05-07 to 'quarter ended June 30, 2026' in the filing dated 2026-08-06.
- Exhibit 10.1 description changed from 'Form of Retention Award Agreement.' in the filing dated 2026-05-07 to 'Form of Retention Award Agreement, filed as Exhibit 10.1 to the Company's Form 10-Q filed on May 7, 2026 and incorporated herein by reference.' in the filing dated 2026-08-06.
- Exhibit 10.2 description changed from 'Form of Performance Stock Unit Award Agreement under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.' in the filing dated 2026-05-07 to include the additional text ', filed as Exhibit 10.2 to the Company's Form 10-Q filed on May 7, 2026 and incorporated herein by reference' in the filing dated 2026-08-06.
- Notes:
- The text provided for both filings appears to include the full Part II of Form 10-Q rather than only the Risk Factors section, so changes reported from Items 2-6 and signatures are outside the Risk Factors section itself.
- The Risk Factors statement itself is substantially identical except for the updated quarter-end date.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-05. The 4 days since 2026-10-05 have not been checked yet.
- Last 90 days · read to 2026-10-050 buys · 1 sell ($329460) — 1 selling insider
- Last 180 days · read to 2026-10-050 buys · 1 sell ($329460) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-26. Based on Form 4 filings read through 2026-10-05; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about EVH's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding EVH as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 18,512,759
- Reported value $100,339,152
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about EVH's institutional holders → See what each manager we track holds →
Short interest (FINRA)
EVH had 14,068,069 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
EVH had 12.4% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.81 days to cover at the same settlement.
- Reported short interest (shares) 14,068,069
- Short interest (% of shares outstanding) 12.4%
- Prior settlement (shares) 15,469,700
- Reported change -9.06%
- Days to cover (reported) 5.81
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Magellan Health
- Carelon (Elevance Health)
- Optum (UnitedHealth Group)
- Cotiviti
- HealthHelp (WNS)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
EVOLENT HEALTH INC CLASS A is found in…
Frequently asked questions
What does EVOLENT HEALTH INC CLASS A (EVH) do?
Evolent Health provides specialty care management services, primarily focused on oncology, cardiology, and musculoskeletal conditions, to help health plans and risk-bearing entities manage complex patient needs. The company utilizes clinical pathways, provider network management, and proprietary technology to reduce healthcare costs and improve clinical outcomes for patients.
What sector is EVOLENT HEALTH INC CLASS A (EVH) in?
EVOLENT HEALTH INC CLASS A (EVH) is classified in the Health Care sector. Its industry is Health care services / population health management. It trades on NYSE.
Who are EVOLENT HEALTH INC CLASS A's (EVH) competitors?
Notable peers of EVOLENT HEALTH INC CLASS A (EVH) include Magellan Health, Carelon (Elevance Health), Optum (UnitedHealth Group), Cotiviti and HealthHelp. This peer set is informational only — not financial advice.
Is EVOLENT HEALTH INC CLASS A (EVH) overbought or oversold right now?
EVOLENT HEALTH INC CLASS A (EVH) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 53, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on EVH come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.